ProBioGen AG, a premier service and technology provider for complex therapeutic antibodies and glycoproteins, today announced the closing of a license agreement with Bayer AG for the GlymaxX® Technology. Under the terms of the agreement, Bayer will…
Eckert & Ziegler AG (ISIN DE0005659700), a specialist in isotope-related applications in medicine, science and industry, has been given the manufacturing authorization for additional production lines for its Ge-68/Ga-68-generators (GalliaPharm®). The…
Will Enhance Surgical Skills and Enable a Higher Quality of Care for Both Patients and Caregivers
Eckert & Ziegler AG (ISIN DE0005659700), a global radioisotope specialist headquartered in Berlin, Germany, has formed a joint venture with Chinese TCL Healthcare Equipment (Shanghai) Co., Ltd. (TCL Healthcare) for the development, production and…
Eckert & Ziegler AG (ISIN DE0005659700), a global radioisotope specialist headquartered in Berlin, Germany, has formed a joint venture with Chinese TCL Healthcare Equipment (Shanghai) Co.
The deadline for submission of proposals will be on the 28th of October 2019.
Myelo Therapeutics GmbH announced today that the European Medicines Agency (EMA) has granted an Orphan Drug Designation to its orally applied new chemical entity Myelo001 (Imidazolyl ethanamide pentandioic acid) for the treatment of Acute Radiation…
The Open Call for European Business Networks (EBNs) is launched on the 22nd of July and it will be open until the 3rd of November 2019, 17:00h Brussels time.
BioRiver Boost! 2019 - the competition for Life Science founders for best business contacts / applications until 31st August 2019 / Finalists profit from direct contacts to market leaders and decision-makers
German Research Minister Anja Karliczek and Governing Mayor of Berlin Michael Müller signed an administrative agreement between the federal government and the state of Berlin that lays out the details for the integration of the Berlin Institute of…
